(Q33595442)

28 July 2017

1 reference

title

Topical treatment of melasma (English)

1 reference

28 July 2017

author name string

Debabrata Bandyopadhyay

series ordinal

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

Indian Journal of Dermatology

28 July 2017

published in

1 reference

28 July 2017

volume

54

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

303-309

1 reference

Clinical efficacy of 25% L-ascorbic acid (C'ensil) in the treatment of melasma

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Skin lightening preparations and the hydroquinone controversy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Hyperpigmentation and melasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

New and experimental treatments of cloasma and other hypermelanoses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Therapeutical approaches in melasma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Origin, clinical presentation, and diagnosis of facial hypermelanoses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

The treatment of melasma: a review of clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Topical treatments for melasma and postinflammatory hyperpigmentation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Topical agents used in the management of hyperpigmentation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Exogenous ochronosis. An update on clinical features, causative agents and treatment options

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Allergic contact dermatitis from a bleaching cream

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

A New Formula for Depigmenting Human Skin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Exogenous ochronosis following hydroquinone for melasma.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

A promising new treatment for solar lentigines.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Adapalene in the treatment of melasma: a preliminary report

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Melasma: histopathological characteristics in 56 Korean patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2807702

Protective effect of magnesium-L-ascorbyl-2 phosphate against skin damage induced by UVB irradiation

30 October 2018

1 reference

12 December 2020

Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase

1 reference

12 December 2020

Pigmentary disorders in the South East

1 reference

12 December 2020

Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma

1 reference

12 December 2020

Depigmenting effect of alpha-tocopheryl ferulate on normal human melanocytes

1 reference

12 December 2020

Melasma in men. A clinical and histologic study

1 reference

12 December 2020

Contact allergy to kojic acid in skin care products

1 reference

12 December 2020

Topical liquiritin improves melasma

1 reference

12 December 2020

Exogenous ochronosis: an epidemiological study

1 reference

12 December 2020

N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma

1 reference

12 December 2020

Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo

1 reference

12 December 2020

Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible

1 reference

12 December 2020

The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation

1 reference

12 December 2020

The Treatment of Melasma 20% Azelaic Acid versus 4% Hydroquinone Cream

1 reference

12 December 2020

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial

1 reference

12 December 2020

Treatment of melasma with potent topical corticosteroids

1 reference

12 December 2020

Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid

1 reference

12 December 2020

Pigmentary disorders in India

1 reference

12 December 2020

Mechanism of depigmentation by hydroquinone

1 reference

12 December 2020

Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent

1 reference

12 December 2020

The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions

1 reference

12 December 2020

Treatment of Melasma (Chloasma) by Local Application of a Steroid Cream

1 reference

12 December 2020

Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial

1 reference

12 December 2020

The inhibitory effect of DL-alpha-tocopheryl ferulate in lecithin on melanogenesis

1 reference

12 December 2020

Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

1 reference

12 December 2020

Identifiers

DOI

10.4103/0019-5154.57602

1 reference

28 July 2017

1 reference

28 July 2017

1 reference